459 related articles for article (PubMed ID: 34725963)
1. Clofarabine monotherapy in two patients with refractory Langerhans cell histiocytosis.
Irie M; Nakano T; Katayama S; Suzuki T; Moriya K; Watanabe Y; Suzuki N; Saitoh-Nanjyo Y; Onuma M; Rikiishi T; Niizuma H; Sasahara Y; Kure S
Cancer Rep (Hoboken); 2022 Aug; 5(8):e1579. PubMed ID: 34725963
[TBL] [Abstract][Full Text] [Related]
2. Clofarabine monotherapy in aggressive, relapsed and refractory Langerhans cell histiocytosis.
Parekh D; Lin H; Batajoo A; Peckham-Gregory E; Karri V; Stanton W; Scull B; Fleishmann R; El-Mallawany N; Eckstein OS; Prudowsky ZD; Gulati N; Agrusa JE; Ahmed AZ; Chu R; Dietz MS; Goldman SC; Hogarty MD; Imran H; Intzes S; Kim JM; Kopp LM; Levy CF; Neff P; Pillai PM; Sisk BA; Schiff DE; Trobaugh-Lotrario AD; Walkovich K; McClain KL; Allen CE
Br J Haematol; 2024 May; 204(5):1888-1893. PubMed ID: 38501389
[TBL] [Abstract][Full Text] [Related]
3. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai-Dorfman disease.
Simko SJ; Tran HD; Jones J; Bilgi M; Beaupin LK; Coulter D; Garrington T; McCavit TL; Moore C; Rivera-Ortegón F; Shaffer L; Stork L; Turcotte L; Welsh EC; Hicks MJ; McClain KL; Allen CE
Pediatr Blood Cancer; 2014 Mar; 61(3):479-87. PubMed ID: 24106153
[TBL] [Abstract][Full Text] [Related]
4. [Lenalidomide induced therapeutic response in a patient with aggressive multi-system Langerhans cell histiocytosis resistant to 2-chloro-deoxyadenosine and early relapsing after high-dose BEAM chemotherapy with autologous peripheral blood stem cell transplantation].
Adam Z; Rehák Z; Koukalová R; Szturz P; Krejčí M; Pour L; Zahradová L; Moulis M; Kodet R; Nebeský T; Brejcha M; Adamová Z; Hájek R; Mayer J
Vnitr Lek; 2012 Jan; 58(1):62-71. PubMed ID: 22448704
[TBL] [Abstract][Full Text] [Related]
5. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis.
Abraham A; Alsultan A; Jeng M; Rodriguez-Galindo C; Campbell PK
Pediatr Blood Cancer; 2013 Jun; 60(6):E19-22. PubMed ID: 23255383
[TBL] [Abstract][Full Text] [Related]
6. Clofarabine in refractory Langerhans cell histiocytosis.
Rodriguez-Galindo C; Jeng M; Khuu P; McCarville MB; Jeha S
Pediatr Blood Cancer; 2008 Nov; 51(5):703-6. PubMed ID: 18623218
[TBL] [Abstract][Full Text] [Related]
7. [Cladribine for 13 cases refractory high-risk children Langerhans cell histiocytosis].
Hu T; Liu R; Li J; Cao J; Zhang L; Li J; Fan W; Zhong D; Shi X
Zhonghua Xue Ye Xue Za Zhi; 2014 Nov; 35(11):985-9. PubMed ID: 25417874
[TBL] [Abstract][Full Text] [Related]
8. Treatment of children with refractory/relapse high risk langerhans cell histiocytosis with the combination of cytarabine, vindesine and prednisone.
Wang W; Ge J; Ma H; Lian H; Cui L; Zhao Y; Li Z; Wang T; Zhang R
BMC Pediatr; 2024 Jan; 24(1):1. PubMed ID: 38172736
[TBL] [Abstract][Full Text] [Related]
9. [Recurrent and Refractory Langerhans Cell Histiocytosis in Children Treated with the Combination of Cladribine and Cytarabine].
DU Y; Xiong H; Li H; Li JX; Tao F; Yang L; Lu WJ; Qi SS; Zhang LN
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Jun; 30(3):943-949. PubMed ID: 35680831
[TBL] [Abstract][Full Text] [Related]
10. Excellent remission rates with limited toxicity in relapsed/refractory Langerhans cell histiocytosis with pulse dexamethasone and lenalidomide in children.
Uppuluri R; Ramachandrakurup S; Subburaj D; Bakane A; Raj R
Pediatr Blood Cancer; 2017 Jan; 64(1):110-112. PubMed ID: 27555565
[TBL] [Abstract][Full Text] [Related]
11. Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease in a Girl: A Rare and Puzzling Diagnosis.
Ocak S; Bayramoglu Z; Tugcu D; Karaman S; Unuvar A; Karakas Z
J Pediatr Hematol Oncol; 2021 Apr; 43(3):e375-e379. PubMed ID: 32097280
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of intermediate-dose cytarabine in the treatment of children with refractory high risk Langerhans cell histiocytosis].
Wang WQ; Ge J; Ma HH; Lian HY; Cui L; Zhang L; Li ZG; Wang TY; Zhang R
Zhonghua Er Ke Za Zhi; 2023 Dec; 61(12):1118-1123. PubMed ID: 38018049
[No Abstract] [Full Text] [Related]
13. [Treatment of Langerhans cells histiocytosis by cladribin reached long-term complete remission in 9 out of 10 adult patients].
Adam Z; Szturz P; Duraš J; Pour L; Krejčí M; Rehák Z; Koukalová R; Navrátil M; Hájek R; Král Z; Mayer J
Klin Onkol; 2012; 25(4):255-61. PubMed ID: 22920165
[TBL] [Abstract][Full Text] [Related]
14. Treatment of refractory Langerhans cell histiocytosis (LCH) with a combination of 2-chlorodeoxyadenosine and cytosine arabinoside.
Apollonsky N; Lipton JM
J Pediatr Hematol Oncol; 2009 Jan; 31(1):53-6. PubMed ID: 19125089
[TBL] [Abstract][Full Text] [Related]
15. 2-Chlorodeoxyadenosine (2-CDA) for the treatment of refractory or recurrent Langerhans cell histiocytosis (LCH) in pediatric patients.
Stine KC; Saylors RL; Williams LL; Becton DL
Med Pediatr Oncol; 1997 Oct; 29(4):288-92. PubMed ID: 9251735
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous remission of 2-chlorodeoxyadenosine (2-CdA)-related secondary myelodysplastic syndrome in a patient with refractory Langerhans cell histiocytosis.
Suzuki D; Kobayashi R; Sano H; Kishimoto K; Yasuda K; Nakanishi M; Nagashima T; Kobayashi K
Int J Hematol; 2013 Jun; 97(6):782-5. PubMed ID: 23616222
[TBL] [Abstract][Full Text] [Related]
17. Clofarabine ± fludarabine with once daily i.v. busulfan as pretransplant conditioning therapy for advanced myeloid leukemia and MDS.
Andersson BS; Valdez BC; de Lima M; Wang X; Thall PF; Worth LL; Popat U; Madden T; Hosing C; Alousi A; Rondon G; Kebriaei P; Shpall EJ; Jones RB; Champlin RE
Biol Blood Marrow Transplant; 2011 Jun; 17(6):893-900. PubMed ID: 20946966
[TBL] [Abstract][Full Text] [Related]
18. Cladribine and cytarabine in refractory multisystem Langerhans cell histiocytosis: results of an international phase 2 study.
Donadieu J; Bernard F; van Noesel M; Barkaoui M; Bardet O; Mura R; Arico M; Piguet C; Gandemer V; Armari Alla C; Clausen N; Jeziorski E; Lambilliote A; Weitzman S; Henter JI; Van Den Bos C;
Blood; 2015 Sep; 126(12):1415-23. PubMed ID: 26194764
[TBL] [Abstract][Full Text] [Related]
19. [Cladribine treatment of repeatedly-relapsed Langerhans cell histiocytosis: a case report and literature review].
Yao X; Ying H; Weihong Z; Qing S; Xintian L
Zhonghua Er Ke Za Zhi; 2015 Apr; 53(4):296-9. PubMed ID: 26182506
[TBL] [Abstract][Full Text] [Related]
20. Improved outcome of refractory Langerhans cell histiocytosis in children with hematopoietic stem cell transplantation in Japan.
Kudo K; Ohga S; Morimoto A; Ishida Y; Suzuki N; Hasegawa D; Nagatoshi Y; Kato S; Ishii E
Bone Marrow Transplant; 2010 May; 45(5):901-6. PubMed ID: 19767778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
